Skip to main contentLast updated: 17-Nov-2026
Tapping Book on WhatsApp will likely open the WhatsApp app on your phone.

Dr Harsh Shah
MS, MCh (Surgical Gastroenterology), DrNB (Surgical Gastroenterology)
Registered with Gujarat Medical Council, Reg. No. G-38738
Stomach Cancer Surgeon
Dr. Jivraj Mehta Hospital, Vasna, Ahmedabad · 18 years of experience
In short
After a GIST is removed, the pathologist sorts it into a risk group: very low, low, intermediate or high. The group shows how likely the tumour is to come back.
Four findings make the group: the size of the tumour, how many cells are dividing, where in the gut it grew, and whether it burst open. A gene result can then move the decision up or down.
The risk group, not the stage, is what usually decides whether you need imatinib tablets after surgery, and for how long.
For the whole story of GIST, from the first test to imatinib and surgery, read our GIST treatment in Ahmedabad page. This post explains the risk group and stage written on your report.
Two GISTs that look alike on a scan can behave very differently. The risk group is how the team tells a tumour that will stay quiet from one that may return.
The group is final only after the whole tumour is studied, which is why it is written on the pathology report of the operation and not on the first biopsy. The tests that come before it are in our post on how a GIST is confirmed with CT, scope and biopsy.
Size, the count of dividing cells, the site in the gut, and rupture. Each one must be written on a good report, and a missing one makes the group uncertain.
Ask whether the count was given for a fixed area, because old reports used a different unit and the two cannot be swapped. A report that says only “malignant” or “benign” without these four details is not enough to plan tablets.
The four findings are read against a standard chart. The version most doctors use today treats a burst tumour as high risk straight away.
| Risk group | What is usually found | Usual next step |
|---|---|---|
| Very low | Up to 2 cm, few dividing cells, not burst | No tablets; routine follow-up |
| Low | 2 to 5 cm, few dividing cells, not burst | No tablets; scans for some years |
| Intermediate | A stomach tumour of 5 to 10 cm with few dividing cells, or a small one with a moderate count | Decided one patient at a time; the gene result helps |
| High | Over 10 cm, or many dividing cells, or a burst tumour, or a small-bowel tumour of middle size | Imatinib after surgery is usually advised |
The chart is a guide to the pattern. Your own group is set by the pathologist from your actual numbers, and Dr Shah reads it together with your scans and your gene result.
The same size and the same count are safer in the stomach than elsewhere. A tumour outside the stomach is placed in a higher group.
A first scan or scope that shows where the tumour started therefore matters. Our post on how the scope and endoscopic ultrasound assess a GIST explains how the layer and the site are read.
Because a burst tumour can scatter cells inside the belly, where they settle on the lining and grow later. This risk is large enough to override every other finding.
This is why a surgeon handles a GIST gently, without squeezing or pulling it with instruments, and removes it whole in a bag. Where possible the tumour is taken out intact, and the pathologist is told if anything went differently.
Yes. The gene result is not part of the chart, but it can raise the decision or lower it, and it often changes which tablet is used.
The meaning of each gene change is in our post on what your GIST gene report means.
Very low and low groups do not need them. A high group usually does. An intermediate group is the one that needs a careful talk.
How surgery and tablets are put in order is explained in our post on surgery or imatinib first: how the order is set, and the studies behind the three-year course are in the key GIST studies and what is new.
Staging uses the common cancer system of tumour size, glands and spread. For GIST it is used for records more than for deciding treatment.
So do not be alarmed by a stage number alone. A stage and a risk group answer different questions, and the risk group is the one that guides your treatment.
Two calculators turn the same findings into a personal chance of staying free of GIST. They are used when a tumour sits close to a dividing line.
Before surgery, the group can only be estimated, since a needle biopsy samples only part of the tumour. The final group is set after the whole tumour is studied.
Five questions cover it. Ask them with the report in your hand.
If any answer is missing, the report is not yet complete. Dr Shah will go through it with you and order what is missing, including a second look by the pathologist.
It is a score from four findings: tumour size, how many cells are dividing, the site in the gut, and whether the tumour burst. It sorts the tumour as very low, low, intermediate or high risk of coming back.
No. The stage describes size, glands and spread in the common cancer system. The risk group says how likely the tumour is to return, and it is the one that guides tablets after surgery.
No. High risk means the chance of return is real, so tablets and closer scans are advised. Many people in this group are treated and watched for years.
Very low and low groups do not. A high group usually does, often for about three years. An intermediate group is decided one patient at a time, using the gene result.
The same size and cell count are safer in the stomach than in the small bowel or the back passage. A tumour outside the stomach is placed in a higher group.
A tumour that bursts can scatter cells into the belly, and these settle and grow later. That risk outweighs every other finding, so the group is high whatever the size.
Then the risk group cannot be fixed. Ask the pathologist for the count over a fixed area of the slide, and for a second look if needed. Dr Shah can arrange this.
For the full picture of GIST and its treatment, start at the GIST treatment in Ahmedabad page. For questions before you travel, call +91-63555-64601.
Dr Harsh Shah — Dr. Jivraj Mehta Hospital, Vasna, Ahmedabad
Dr. Jivraj Mehta Hospital, Dr Jivraj Mehta Marg, Vasna, Ahmedabad 380007.
Consultations, review of reports and scans, operations and follow-up. OPD Monday to Saturday, 9 am to 5 pm.
Appointments: +91-63555-64601 · +91-63590-11009 · Hospital 079-2663 6363
Directions to the hospital · WhatsApp +91-63555-64601
Operated for a GIST, and now the report says "intermediate" or "high risk"? Wondering whether you must take tablets for years? That word is not a verdict. It is a working score made from four findings, and it tells the team how closely to watch you and whether tablets will help. Dr Harsh Shah, a stomach cancer surgeon in Ahmedabad, goes through your risk group with you in plain words. Bring the report. You can call us or book by message. Call For Appointment Book on WhatsApp Tapping Book on WhatsApp will likely open the WhatsApp app on your phone.
Tapping Book on WhatsApp will likely open the WhatsApp app on your phone.
Swasth Parivar: every week, practical advice on recovery, diet and warning signs. No advertising. Stop any time.
Your number is used for these updates and for the clinic to reach you. It is never sold or passed on. To stop, reply STOP on WhatsApp.